Focus on stool diagnostics: An interview with our experts
Analysis of stool samples is a frequent task in clinical diagnostics. Heike Calado Duarte and Carlo Farah from our R&D team talk to us about the challenges involved and what you should pay [...]
After the COVID-19 pandemic: Are diarrheal diseases on the rise again?
During the COVID-19 pandemic, there were significantly fewer infections with diarrhea-causing pathogens such as norovirus. However, with the relaxation of countermeasures against COVID-19, the number [...]
Reliable detection of novel influenza A variants with R-Biopharm RIDA®GENE test systems
Respiratory diseases often show similar symptoms, but are triggered by a variety of pathogens, such as viruses, bacteria and fungi. Rapid, comprehensive and reliable diagnostics as a basis for [...]
Top priority at R-Biopharm: the IVDR
The EU has created a new legal framework for the quality and safety of in-vitro medical devices, namely the IVDR (Regulation on in-vitro diagnostic medical devices), which sets legally binding higher [...]
All RIDA®GENE SARS CoV-2 tests detect the new variant Omicron (B1.1.529) with the usual sensitivity and reliability
The Omicron variant does not show any mutations in the areas detected by our assays and is therefore positively detected by RIDA®GENE SARS-CoV-2 (Art. No. PG6815/ PG6820) and RIDA®GENE Flu & [...]
In the hospital, there is a dangerous visitor: What are the most recent research on Clostridium difficile?
The bacteria Clostridium difficile colonizes every human intestine, although it may be harmful for those with compromised immune systems. It is becoming increasingly prevalent in hospitals. What is [...]
New ELISA test for the monitoring of the Ustekinumab drug level
Studies have shown that some patients do not respond or respond inadequately to therapies for chronic intestinal diseases like for example Inflammatory Bowel Disease. The biologic drug ustekinumab, [...]
Update: Therapeutic drug monitoring for Vedolizumab
Therapeutic drug monitoring (TDM) for the biological Vedolizumab has not been in focus to date. Vedolizumab is a meant or the treatment for inflammatory bowel disease. On Wednesday, September 29, our [...]
World IBD day
For World IBD Day we would like to draw your attention to the Inflammatory Bowel Disease (IBD). About ten million people worldwide (around three million in Europe) suffer from this chronic (lifelong) [...]
Quality controls for SARS-CoV-2 rapid tests and RT-PCR
We complement our control reagent portfolio with new controls including SARS-CoV2 positive and negative controls, as well as all-encompassing validation and verification kits for respiratory and [...]
Back to school in the time of the coronavirus – what can we expect?
The COVID-19 infection figures continue to rise and with them the fear: How long can regular school operations be maintained? Experts warn of renewed school closings and recommend specific measures.
Noninvasive detection of Helicobacter pylori – reliable and safe for the patient
Helicobacter pylori can cause serious diseases. The symptoms of a Helicobacter infection vary widely in their form and expression. Detection is therefore critical for diagnosis and treatment. [...]
Coronavirus test kit receives CE label
In February 2020, R-Biopharm was one of the first diagnostics companies worldwide to launch a test kit for the novel coronavirus SARS-CoV-2. Now, the test has received the CE label and is thus [...]
R-Biopharm announces quality products distribution agreement with Microbix
Mississauga, Canada and Darmstadt, Germany, 15th May 2020 – R-Biopharm AG  and Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator, announces the appointment of R-Biopharm AG [...]
Parkinson’s disease from Helicobacter pylori?
Infection with the stomach bacteria Helicobacter pylori is the most common cause of stomach inflammation (gastritis). Yet, these widespread bacteria can also cause many other diseases—possibly even [...]
Real-time PCR: RIDA®SEEK makes analyses more efficient
Real-time PCR tests offer many advantages and have become an important part of clinical diagnostics. Yet the efficiency of the tests depends also on the software. With the new, automated evaluation [...]
Golimumab: new hope for patients with inflammatory diseases
Highly effective and well tolerated: the anti-inflammatory medication golimumab, known under the trade name Simponi®, is a valuable treatment option for patients with rheumatic diseases as well as [...]
Clostridium difficile: 10 tips for prevention
The intestinal bacterium Clostridium difficile is one of the most common causes of nosocomial infections. Patients whose intestinal flora is disrupted due to the use of antibiotics are particularly [...]
Influenza: well prepared for the 2019/2020 flu season
As temperatures grow colder, the risk of catching the flu virus and spreading the infection among the population rises as well. But what makes the influenza virus so dangerous? For Virus Appreciation [...]
Sexually transmitted infections: the silent epidemic
Sexually transmitted infections/diseases (STIs or STDs) like syphilis, gonorrhea, and chlamydia are on the rise worldwide. But still hardly anyone talks about it.
Distribution of the new innovative molecular diagnostics platform Vivalytic starts
aprimeo diagnostics GmbH & Co. KG, a R-Biopharm AG company, starts distribution of the new innovative molecular diagnostics platform Vivalytic from Bosch
IBD therapy: 5 reasons for using drug monitoring
More than five million people worldwide suffer from chronic inflammatory bowel disease (IBD) including Crohn’s disease and ulcerative colitis. World IBD Day on May 19 brings awareness to this [...]
ADM monitoring: performance of a rapid test versus conventional ELISA
Adalimumab (ADM) revolutionized the treatment of patients with inflammatory bowel diseases. Despite its therapeutic success, up to 40 % of patients do not respond to adalimumab induction treatment [...]
On the trail of rare diseases
Five percent of people in Germany suffer from a rare disease. On the occasion of Rare Disease Day, February 28th, 2019, we will take a closer look at one of them.
Gastroenteritis: Keep an eye on these viruses
Gastroenteritis, also known as the stomach flu, is one of the most frequent illnesses in humans worldwide. Often it is viruses that are responsible for the infection.
Automation in diagnosis of allergies
As allergies become more widespread, their diagnosis takes on an important role. For this purpose, laboratory tests that detect allergen-specific antibodies in the blood are indispensable tools. [...]
The usefulness of rapid testing
Patients with Crohn’s disease, ulcerative colitis or other inflammatory diseases are often treated with adalimumab. However, long-term therapy success is not always achieved. As a recent study [...]
Validation of the RIDA®QUICK ADM Monitoring
RIDA®QUICK ADM Monitoring is a rapid test for adalimumab drug concentration monitoring which supports timely dose adjustments in clinical practice. A poster about the validation of the test was [...]
Clostridium difficile: Detect infections with certainty
Clostridium difficile is one of the most frequent pathogens in nosocomial infections – but in spite of this many people have never heard of it. Since November is officially “Clostridium [...]
Back pain: Bechterew’s disease is often overlooked
An estimated 540 million people worldwide suffer from lower back pain. When the pain becomes chronic, a rheumatic illness such as Bechterew’s disease may be the cause.
Influenza: An underestimated infectious disease
The year’s wet and cold season begins in October along with the annual flu season. After an extraordinarily severe flu wave in 2017/18, experts are warning that the flu should not be underestimated.
Colon cancer screening: Invitation process begins
Through early detection, almost all colorectal cancers can be cured or even prevented. The exam is effective and simple – and it is not performed often enough. The new invitation process is [...]
Available now: The complete package for therapeutic drug monitoring
Chronic inflammatory diseases like Crohn’s disease, ulcerative colitis, and rheumatism respond well to treatment with the TNF-α blockers infliximab and adalimumab. Monitoring the concentration [...]
A silent companion in the stomach harbors dangers: Helicobacter pylori
More than half of the world’s population suffers from an inflammation of the gastric mucosa called gastritis. These patients are at risk of developing a gastric ulcer, a duodenal ulcer or even [...]
Colon cancer screening: A test procedure must meet these requirements
The guideline of the Joint National Committee (G-BA) requires laboratories to switch to a new test procedure for early detection of colon cancer. We have summarized what you need to consider in [...]
Zoonotic diseases back on the advance
Now that summer is here, people are spending more and more time outside. Warm temperatures certainly make activities like swimming, hiking, jogging and picnicking more attractive. But forests and [...]
R-Biopharm enters into collaboration with Statens Serum Institute in the field of tuberculosis diagnostics
Darmstadt, Germany, June 27, 2018 – R-Biopharm Group announced today a collaborative agreement with Statens Serum Institute (SSI, Denmark), focusing on discovery and development of novel diagnostic [...]
More efficient and flexible: RIDA®GENE real-time PCR kits in the new format
The new generation of the RIDA®GENE multiplex real-time PCR kits offers a number of improvements—and makes molecular laboratory diagnostics even more efficient and flexible.
Laboratory 4.0: How automation improves diagnostics
The lab — a place for science and research where experiments and tests are on the daily agenda. Yet the world of the laboratory is changing. Digitalization and automation mark a new era. For World [...]
R-Biopharm and ELITechGroup announced a worldwide agreement to expand their real-time PCR assay portfolio
Darmstadt, Germany and Puteaux, France, April 19, 2018 – R-Biopharm, a globally active life science company, and ELITechGroup, a leading company in sample-to-result molecular diagnostics, announced [...]
Sexually transmitted infections: the silent epidemic
Sexually transmitted infections/diseases (STIs or STDs) like syphilis, gonorrhea, and chlamydia are on the rise worldwide. But hardly anyone talks about it. To mark STD Awareness Month, we explain [...]
Five reasons to get colorectal cancer screening
In Germany, more than 60,000 people contract colon cancer every year; over 25,000 die of the disease. Early detection could have prevented many such cases – yet in spite of that, only one in every [...]
R-Biopharm AG & Bosch Healthcare Solutions partner to develop molecular diagnostics for automated all-in-one platform
R-Biopharm AG today announced that it has entered into a collaboration with Bosch Healthcare Solutions. Under the agreement, R‑Biopharm AG develops, manufactures and commercializes molecular [...]
Vedolizumab: New option for IBD patients
If conventional IBD treatments aren’t working, vedolizumab is an alternative. Therapeutic drug monitoring helps improve treatment success with vedolizumab.
Influenza: Well-armed for the 2017/2018 flu season
As temperatures grow colder, the risk of catching the flu virus rises as well. This year, Australia is experiencing the worst flu epidemic in 15 years. Are Europe and North America also facing the [...]
Smart idea with high performance: Microspot arrays revolutionize clinical diagnostics
Microspot arrays facilitate efficient and high-quality multiplex diagnostics for any sample throughput. They are also convenient, flexible, and automatable. This innovative technology is available [...]
Illness due to parasites: What you need to know about zoonoses
Zoonoses are infectious diseases which can be transmitted from animals to humans. More than 200 of these diseases are known. On World Zoonoses Day on July 6 we are presenting the most common [...]
Type III allergies: identifying and treating delayed food allergies
Can you tolerate these foods? More and more people can’t due to food allergies. On the occasion of Food Allergy Day, we reported last week on type I allergies. Today, we will devote our [...]
Accurately diagnose food allergies in childhood
Not all allergies are alike. At the food allergy awareness day on June 21st, we will be dealing with food allergies in children and will show what is actually important for a diagnosis.
Adalimumab monitoring improves therapy success
The drug adalimumab is used very successfully in the treatment of various inflammatory diseases. Yet in some patients, the efficacy of this drug decreases over time. We explain why this is so and how [...]
World IBD Day: Five myths about inflammatory bowel diseases
May is completely characterized by intestinal health: first Digestive Disease Week, now World IBD Day. The aim of the IBD action day is to raise awareness about inflammatory bowel diseases (IBDs). [...]
Therapeutic drug monitoring: Greater efficiency through quick tests
Therapeutic drug monitoring (TDM) is used to measure the concentration of an active ingredient in the patient’s blood. Using this information, physicians can adjust the dose individually to the [...]
Tick season is here: Diagnosis of TBE/FSME made easy
Tick season has started and the risk of dangerous infections with TBE/FSME is increasing. In the event of a suspected infection and to clarify immunization, antibody detection is the method of choice.
Colon cancer awareness month: Early detection can save lives
As every year, March is officially “Colon Cancer Awareness Month”. A great opportunity to highlight the importance of screening. Nowadays, modern tests have made the early detection of colon [...]
Better therapy, lower costs: Optimizing the treatment of IBD
So-called TNFα blockers are commonly used in the treatment of inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis. Therapeutic drug monitoring improves the effect of the [...]
Helicobacter pylori & its resistance against clarithromycin – detect it simultaneously!
RIDA®GENE Helicobacter pylori is a sensitive and specific real-time PCR assay. It simultaneously detects and differentiates Helicobacter pylori and its resistance to clarithromycin in human tissue [...]
Detection of legionella with RIDASCREEN® Legionella
The new assay RIDASCREEN ® Legionella of R-Biopharm closes the gap in test portfolio for the detection of life-threatening infectious diseases.
RIDA qLine® Allergy quality assessment: Register now!
R-Biopharm starts RIDA qLine® Allergy External Quality Assessment. This new tool will help to ensure the quality of the testing procedures in laboratories using RIDA qLine® Allergy and the [...]
Safe into the upcoming influenza season with RIDA®GENE real-time PCR assays
The RIDA®GENE real-time PCR assays (RIDA®GENE Flu, RIDA®GENE Flu LC2.0, RIDA®GENE Flu & RSV) successfully detected the suggested vaccination strains for influenca of the 2015/2016 season.
Inflammatory bowel disease – TNFalpha blocker treatment and calprotectin
Chronic inflammatory bowel disease (IBD) is characterized by recurring and often ongoing flares. The most common forms of IBD are Crohns disease and Ulcerative colitis.
Diabetes mellitus and pancreatic insufficiency
Almost 50 % of type one diabetics and about 33 % of type 2 diabetics will develop a pancreatic insufficiency in the course of their disease.
Differentiation of IBD and IBS with Calprotectin in Stool
It is often difficult to differentiate patients with inflammatory bowel disease (IBD) those who suffer from irritable bowel syndrome due to similar symptoms of patients. Both groups show similar [...]
Colon cancer prevention with immunological stool tests
According to the Robert Koch Institute (RKI) every year 63.000 people in Germany fall ill with colon cancer. Approximately 25,000 people die annually from the consequences of this disease. Colon [...]
TNFalpha blocker and drug monitoring
TNFalpha blocker are biologic agents, which are used for the treatment of inflammatory diseases such as Ulcerative Colitis, Crohns disease and Rheumatoid Arthritis. Infliximab as well as Adalimumab [...]
Calprotectin predicts relaps after stopping TNFα treatment
Molander et al. investigated if concentrations of fecal calprotectin can be used for predicting relaps after stopping TNFα blocking therapy in patients with Ulcerative Colitis and Morbus Crohn.
Drug monitoring reduces Infliximab treatment costs
Study about first randomized, controlled testing shows that clinical treatment decisions based on therapeutic drug monitoring (TDM) is superior to dose-intensification strategy.
Influenza season 2015 dominated by new influenza A variant (H3N2)
The RIDA®GENE real-time PCR assays for the detection of Influenza (RIDA®GENE Flu, RIDA®GENE Flu LC2.0, RIDA®GENE Flu & RSV) detect the currently circulating drift variant of influenza A (H3N2).
Drug monitoring of infliximab biosimilars
Ann Gils and her colleagues from KU Leuven evaluated if the biosimilars were equally well quantified as the original infliximab (IFX) drug in their clinically validated infliximab assay.
Legionella and mycoplasma pneumoniae: New RIDA®GENE products for detection of atypical CAP bacteria
Community-acquired pneumonia (CAP) is the most common fatal infectious disease in western countries. Bacteria are the most common pathogens causing CAP, where one differentiates between typical and [...]
Therapeutic drug monitoring of Infliximab
RIDASCREEN® IFX Monitoring is an enzyme linked immunoassay intended for the quantitative determination of infliximab (IFX, anti-TNFα) in human serum and plasma.Â
3rd time in a row: Deloitte Sustained Excellence Award
Sustainable excellence in longterm and profitable growth awarded After awards in 2010 and 2013, R-Biopharm AG has won the Deloitte Sustained Excellence Award for the third time in a row this [...]
New: RIDA®GENE Parainfluenza
Human parainfluenza viruses (HPIV) can cause both upper respiratory infections and lower respiratory infections.
RIDA®GENE Enterovirus: New real-time RT-PCR assay
RIDA®GENE Enterovirus – the new real-time RT-PCR assay for the detection of the major human enteroviruses
Pancreatic insufficiency in diabetes & mucoviscidosis patients
About 50 % of Type-1-Diabetics, 33 % Type-2-Diabetics and 75 – 80 % Mucoviscidosis patients develop exocrine pancreatic insufficiency in the course of their illness (Hardt PD, Pancreatology, [...]
RIDA qLine® Allergy: The next generation of allergy in-vitro diagnostics
R-Biopharm AG has faced the challenge to develop a sophisticated allergy in vitro test system that combines both a quantitative determination and a very economic and easy handling.
New line blot immunoassays: RIDA®LINE Helicobacter IgG & lgA
New line blot immunoassays – reliable differentiation between human IgG and IgA antibodies against Helicobacter pylori type I and II strains
Fastest of its kind: New molecular biological test for the specific detection of EHEC bacteria
R-Biopharm (Darmstadt) has brought to the market the fastest assay currently available for the specific detection of enterohemorrhagic Escherichia coli (EHEC). With the new RIDA®GENE EHEC/EPEC rapid [...]
Histamin release assays for cellular allergy diagnostics and autoreactive urticaria
The Danish company REFLAB became a member of the R-Biopharm group on January 1, 2010. As a supplier of test kits for the detection of autoreactive urticaria and histamine release tests for the [...]
RIDASCREEN® Norovirus 3rd Generation antigen EIA
Your first step in the diagnosis of noroviral gastroenteritis outbreaks, powered by R-Biopharm Noroviruses, the most common cause of acute gastroenteritis are estimated to cause 21 million people [...]